Despite the pandemic, and, in some cases, because of it, M&A in the technology, media and telecommunications (TMT) sector has flourished. According to our survey with Wolf Theiss, it will continue to do so.
While the pandemic hit deal volume in the sector, value increased on the back of a lucrative banking deal in Hungary. Meanwhile our survey with Wolf Theiss shows optimism for post-COVID dealmaking.
The financial crisis saw banks retreat and private lenders emerge. In the years since, this once-nascent trend has become increasingly mainstream. And our survey with Wolf Theiss reveals that private backing for deals in CEE is only going to grow.
Three big deals and an increase in value covered up a big dip in M&A volume in the real estate and construction sector. And the outlook for the industry is very mixed, according to our survey with Wolf Theiss.
In Wolf Theiss' series focusing on key markets in the CEE/SEE, we shine a light on Hungary.
In Wolf Theiss' series focusing on key markets in the CEE/SEE, we explore Romania, which is ripe for an M&A revival.
The global pandemic, ageing populations and the burgeoning biotech subsector mean that the pharmaceuticals, medical and biotech (PMB) sector is set to see robust M&A activity in 2021.
In Wolf Theiss' series focusing on key markets in the CEE/SEE, we look at the Czech Republic, where dealmaking was relatively stable despite the pandemic.
Despite, the pandemic hitting volume, the biggest deal in the region saw value in industrials and chemicals M&A rise significantly.
In Wolf Theiss' series focusing on key markets in the CEE/SEE, we turn our attention to Austria, which saw an upturn in its dealmaking fortunes in 2020.
The dealmaking climate in the energy, mining and utilities (EMU) sector in 2020 was distinctly gloomy, and the outlook for the coming year is mixed, according to our survey with Wolf Theiss.
In Wolf Theiss' series focusing on key markets in the CEE/SEE, we turn our attention to Poland, the largest economy in the region.
Lockdowns and a lack of discretionary spending hit M&A hard last year, but vaccines and distressed deals promise a brighter 2021.
No more items to load
Load moreAn error occurred trying to play the stream. Please reload the page and try again.
Close
